chr11-57606019-T-A
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM1PM2PP3_Strong
The NM_000062.3(SERPING1):c.695T>A(p.Ile232Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000062.3 missense
Scores
Clinical Significance
Conservation
Publications
- hereditary angioedema with C1Inh deficiencyInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- C1 inhibitor deficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary angioedema type 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary angioedema type 2Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1Other:1
- -
This sequence change replaces isoleucine, which is neutral and non-polar, with lysine, which is basic and polar, at codon 232 of the SERPING1 protein (p.Ile232Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with hereditary angioedema (PMID: 22994404; Invitae). ClinVar contains an entry for this variant (Variation ID: 68255). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SERPING1 protein function. This variant disrupts the p.Ile232 amino acid residue in SERPING1. Other variant(s) that disrupt this residue have been observed in individuals with SERPING1-related conditions (PMID: 26154504), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Uncertain:1
The p.I232K variant (also known as c.695T>A), located in coding exon 4 of the SERPING1 gene, results from a T to A substitution at nucleotide position 695. The isoleucine at codon 232 is replaced by lysine, an amino acid with dissimilar properties. This variant was detected in one patient with a diagnosis of hereditay angioedema, but absent in 53 healthy control individuals (Xu YY, Allergy 2012; 67(11):1430-6). This variant was previously reported in the SNPDatabase as rs281875172. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since clinical data on this variant is limited at this time, its clinical significance is unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at